Poolbeg Pharma - Key POLB 002 European Patent Granted

Jeremy Skillington, PhD, CEO of Poolbeg Pharma, discusses the continued expansion of the POLB 002 patent family following European Patent Office approval.

Jeremy Skillington
Chief Executive Officer

Company Events - POOLBEG PHARMA